Gritstone Bio Inc [NASDAQ: GRTS] closed the trading session at $0.74. The stocks have a year to date performance of -63.78 percent and weekly performance of -26.84 percent. The stock has been moved at -69.72 percent over the last six months. The stock has performed
Gritstone Bio Inc [NASDAQ: GRTS] traded at a low on Wednesday, posting a -3.31 loss after which it closed the day’ session at $0.95. The company report on April 8, 2024 at 8:00 AM that Gritstone bio to Participate in Upcoming Investor and Scientific Conferences.
Gritstone Bio Inc [NASDAQ: GRTS] closed the trading session at $2.35. The company report on April 1, 2024 at 11:00 PM that Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering. The offering consists of (i) 8,333,333 shares of common stock and accompanying common
Gritstone Bio Inc [NASDAQ: GRTS] surged by $0.41 during the normal trading session on while it closed the day at $2.59. The company report on March 5, 2024 at 4:05 PM that Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides
Gritstone Bio Inc [NASDAQ: GRTS] stock went on an upward path that rose over 4.69% on Thursday, amounting to a one-week price decrease of less than -9.35%. The company report on February 8, 2024 at 4:30 PM that Gritstone bio Announces Inducement Grants Under Nasdaq
Gritstone Bio Inc [NASDAQ: GRTS] loss -10.84% or -0.31 points to close at $2.55 with a heavy trading volume of 7024985 shares. The company report on January 17, 2024 at 7:00 AM that Gritstone bio to Participate in Upcoming Investor Conference. Gritstone bio, Inc. (Nasdaq:
© 2024, Powered by Smart TechOne
